Campbell Newman Asset Management Inc Corcept Therapeutics Inc Transaction History
Campbell Newman Asset Management Inc
- $1.17 Billion
- Q4 2024
A detailed history of Campbell Newman Asset Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 49,127 shares of CORT stock, worth $2.78 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
49,127
Previous 49,374
0.5%
Holding current value
$2.78 Million
Previous $2.28 Million
8.36%
% of portfolio
0.21%
Previous 0.18%
Shares
26 transactions
Others Institutions Holding CORT
# of Institutions
402Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$937 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$573 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$459 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$351 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$217 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.07B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...